Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Stascheit

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Der Nervenarzt|March 30, 2023
[Myasthenia in adults, children, and adolescents: what's new?]Frauke Stascheit, Adela Della Marina, Andreas Meisel
Journal of Neuroimmunology|July 23, 2015
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosisFrauke Stascheit, Friedemann Paul, Lutz Harms, et al.
European Journal of Neurology|June 18, 2022
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case seriesFrauke Stascheit, Anne Rübsam, Carolin Otto, et al.
Journal of Neuroimmunology|January 2, 2021
Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis - A report of two casesFrauke Stascheit, Linna Li, Knut Mai, et al.
Frontiers in Neurology|September 30, 2021
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease ActivityFrauke Stascheit, Benjamin Hotter, Sarah Klose, et al.
Neuromuscular Disorders : NMD|May 19, 2025
278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The NetherlandsSabrina Sacconi, Fiammetta Vanoli, Frauke Stascheit, et al.
Neuromuscular Disorders : NMD|January 3, 2026
Monoclonal Gammopathy - the common denominator of sporadic late-onset nemaline myopathy and paraproteinemic neuropathyEleonora Torchia, Frauke Stascheit, Felix Kleefeld, et al.
BMC Neurology|December 8, 2022
Myasthenia gravis - a retrospective analysis of e-mail inquiries made to a patient organisation and specialized center to uncover unmet needs from patients and caregiversMaike Stein, Sarah Hoffmann, Lea Gerischer, et al.
Ebiomedicine|June 25, 2026
Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activityAmol Keshavasa Bhandage, Frauke Stascheit, Hannah Preßler, et al.
Journal of Translational Autoimmunity|August 30, 2021
Calprotectin as potential novel biomarker in myasthenia gravisFrauke Stascheit, Benjamin Hotter, Sarah Hoffmann, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Der Nervenarzt|March 30, 2023
[Myasthenia in adults, children, and adolescents: what's new?]Frauke Stascheit, Adela Della Marina, Andreas Meisel
Journal of Neuroimmunology|July 23, 2015
Toxoplasma gondii seropositivity is negatively associated with multiple sclerosisFrauke Stascheit, Friedemann Paul, Lutz Harms, et al.
European Journal of Neurology|June 18, 2022
Anti-CD20 therapy for multiple sclerosis-associated uveitis: A case seriesFrauke Stascheit, Anne Rübsam, Carolin Otto, et al.
Journal of Neuroimmunology|January 2, 2021
Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis - A report of two casesFrauke Stascheit, Linna Li, Knut Mai, et al.
Frontiers in Neurology|September 30, 2021
Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants-A Potential Novel Biomarker of Disease ActivityFrauke Stascheit, Benjamin Hotter, Sarah Klose, et al.
Neuromuscular Disorders : NMD|May 19, 2025
278th ENMC International Workshop: European standards for harmonization of myasthenia gravis registries and emerging digital solutions. 20th-21st September 2024, Hoofddorp, The NetherlandsSabrina Sacconi, Fiammetta Vanoli, Frauke Stascheit, et al.
Neuromuscular Disorders : NMD|January 3, 2026
Monoclonal Gammopathy - the common denominator of sporadic late-onset nemaline myopathy and paraproteinemic neuropathyEleonora Torchia, Frauke Stascheit, Felix Kleefeld, et al.
BMC Neurology|December 8, 2022
Myasthenia gravis - a retrospective analysis of e-mail inquiries made to a patient organisation and specialized center to uncover unmet needs from patients and caregiversMaike Stein, Sarah Hoffmann, Lea Gerischer, et al.
Ebiomedicine|June 25, 2026
Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activityAmol Keshavasa Bhandage, Frauke Stascheit, Hannah Preßler, et al.
Journal of Translational Autoimmunity|August 30, 2021
Calprotectin as potential novel biomarker in myasthenia gravisFrauke Stascheit, Benjamin Hotter, Sarah Hoffmann, et al.
Pageof 6